Abstract

Imidazo[1,2-a]pyridine derivatives, exhibiting good biological activity, are widely present in drug molecules. The title compound (S)-N-(1-phenylethyl)-6-(4-(trifluoromethoxy)phenyl)imidazo[1,2-a]pyridine-2-carboxamide was designed and synthesized, and the structure was characterized by spectroscopic techniques. The single crystal structure of the target molecule was confirmed by X-ray diffraction, and the optimized molecular crystal structures were determined on the basis of density functional theory (DFT) calculations using B3LYP/6–311+G(2d, p) functional, and compared with the X-ray diffraction data. The molecular structure optimized by DFT was consistent with the crystal structure determined by X-ray single crystal diffraction. The geometrical parameters, molecular electrostatic potential (MEP), and frontier molecular orbital (FMO) analysis of the titled compound are also presented. Vibrational and antitumor analyses of MCF-7 and A375 were also performed in this research.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.